U.S. Secretary of Defense Pete Hegseth announced a new Department of Defense policy on July 17, 2026 [1], to screen military personnel for low testosterone levels.
The initiative marks a significant shift in military health priorities by focusing on hormonal health as a metric for readiness. Officials said that soldiers are at a particular risk of hypogonadism, and the screening could improve overall health and performance [3].
The plan seeks to identify service members with low testosterone to provide medical interventions. By integrating these screenings into the Pentagon's health framework, the administration aims to optimize the physical and mental capabilities of the force.
Reactions to the policy have been polarized. Some observers said the plan was unusual but not crazy [1]. Others have been more critical, with some commentators suggesting the move is a result of a "testosterone craze" typically seen in gym culture [2].
On the program "The View," the policy faced sharp mockery. Sara Haines asked, "What Are They Doing Next, Measuring Penis Size?" while Ana Navarro said the plan was "little crazy" [4, 5].
Medical professionals have also raised questions regarding the implementation of the screening. Doctors said they questioned the plan to screen military members for low testosterone, focusing on the necessity of such broad testing [3].
Despite the criticism, the Department of Defense maintains that the screenings are a necessary step in ensuring the operational effectiveness of the U.S. military. The program will focus on identifying hormonal deficiencies that may impair a soldier's ability to perform duties in high-stress environments.
“Soldiers are at particular risk of hypogonadism and the screening could improve health and performance.”
This policy reflects an effort by the current Defense Department leadership to merge wellness trends with military readiness. By targeting hypogonadism, the Pentagon is treating hormonal optimization as a component of combat effectiveness, though the move risks politicizing military medicine and inviting scrutiny over the clinical necessity of mass screening.
